AbbVie To Buy Pharmacyclics For $21 Billion In A Mixed Cash And Stock Deal
March 05, 2015 at 12:57 PM EST
With the high-priced acquisition scheduled to close mid-year, shares of PCYC are up 10% to above $254 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.